INFUSYSTEM HOLDINGS, INC Impairment of Long-Lived Assets Held-for-use
INFUSYSTEM HOLDINGS, INC (INFU) reported Impairment of Long-Lived Assets Held-for-use of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2021-03-22
- INFUSYSTEM HOLDINGS, INC impairment of long-lived assets held-for-use for fiscal 2020 was $0.00.
- INFUSYSTEM HOLDINGS, INC impairment of long-lived assets held-for-use for fiscal 2019 was $0.00.
- INFUSYSTEM HOLDINGS, INC impairment of long-lived assets held-for-use for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- INFUSYSTEM HOLDINGS, INC impairment of long-lived assets held-for-use for fiscal 2017 was $1.00M.
| Period end | Impairment of Long-Lived Assets Held-for-use 12 month | Impairment of Long-Lived Assets Held-for-use 12 month as first filed |
|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-22 | |
| 2019-12-31 | $0.00 10-K · filed 2021-03-22 | |
| 2018-12-31 | $0.00 10-K · filed 2019-03-22 | |
| 2017-12-31 | $1.00M 10-K · filed 2019-03-22 | |
| 2016-12-31 | $0.00 10-K · filed 2018-03-19 | $641.00K 10-K · filed 2017-03-22 |
| 2015-12-31 | $591.00K 10-K · filed 2017-03-22 | |
| 2014-12-31 | $281.00K 10-K/A · filed 2016-12-12 | |
| 2013-12-31 | -$47.00K 10-K · filed 2015-03-09 | |
| 2012-12-31 | $237.00K 10-K · filed 2014-03-11 | |
| 2011-12-31 | $1.73M 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |